dc.creatorGOMEZ G,CAROLINA
dc.creatorPLESSING R,CARLOS von
dc.creatorGODOY M,C. GLORIA
dc.creatorREINBACH H,ROLANDO
dc.creatorGODOY R,RICARDO
dc.date2005-06-01
dc.date.accessioned2017-03-07T15:25:26Z
dc.date.available2017-03-07T15:25:26Z
dc.identifierhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072005000200008
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/384726
dc.descriptionA practical reversed-phase high-performance liquid chromatography (HPLC) method was developed for 4-chloro-N-furfuryl-5-sulphamoylanthranilic acid (furosemide) determination in plasma. The plasma samples spiked with the drug in presence of propranolol hydrochloride as internal standard, were purified using a liquid - liquid extraction technique. The drugs were separated through a Kromasil 100-5C18 column with a mobile phase composed of acetonitrile and 0.02 M potassium dihydrogen phosphate (34 : 66 v/v) adjusted to pH 3.0 and quantified by fluorescence detection (excitation at 268 nm, emission at 410 nm). The calibration curve was linear ranging between 0.005 and 1.500 mg/mL. The detection limit was 0.001mg/mL and the quantification limit 0.003 mg/mL in plasma. The furosemide recovery from 1mL of plasma was between 99.8 and 101.6 %, with a variation coefficient not higher than 4,85 %. The method is sensitive enough for use in bioavailability and bioequivalence studies after oral administration of 40 mg (a tablet) of furosemide
dc.formattext/html
dc.languageen
dc.publisherSociedad Chilena de Química
dc.sourceJournal of the Chilean Chemical Society v.50 n.2 2005
dc.subject4-chloro-N-furfuryl-5-sulphamoylanthranilic acid
dc.subjecturosemide
dc.subjectliquid-liquid extraction from plasma
dc.subjectHPLC with fluorescence detection
dc.subjectvalidation
dc.titleMETHOD VALIDATION FOR THE DETERMINATION OF FUROSEMIDE IN PLASMA BY LIQUID- LIQUID EXTRACTION AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH FLUORESCENCE DETECTION
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución